• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过与高效辅助性T细胞肽串联结合来改善T细胞对非免疫原性肽的反应。

Improvement of the T-cell response to a non immunogenic peptide by its tandem association with a highly efficient T-helper peptide.

作者信息

Rouaix F, Gras-Masse H, Mazingue C, Ridel P R, Diesis E, Marguerite M, Estaquier J, Capron A, Tartar A, Auriault C

机构信息

Centre d'Immunologie des Maladies Transmissibles et Allergiques, Unité mixte INSERM U167-CNRS 624, Institut Pasteur de Lille, France.

出版信息

Immunopharmacology. 1994 Nov-Dec;28(3):215-22. doi: 10.1016/0162-3109(94)90057-4.

DOI:10.1016/0162-3109(94)90057-4
PMID:7531676
Abstract

The 45-69 peptide, an helper T-cell epitope derived from the HIV nef protein is strongly immunogenic. A T-cell proliferative response was observed following immunization of Lou/M rats with 45-69 peptide administered in low dose and without any adjuvant. It is already known that the T-cell response to the 115-131 peptide of Sm28GST antigen, a protein of the parasite Schistosoma mansoni, requires the presence of a carrier of the use of peptidic constructs. We demonstrate here that a T-cell response against the 115-131 peptide can be obtained in the absence of adjuvant using peptidic constructs (115-45 and 45-115 peptides) resulting from tandem synthesis of 115-131 and 45-69 peptides. A covalent association of both peptides is necessary, since the coinjection of 45-69 and 115-131 peptides is not sufficient to induce a detectable anti-115-131 T-cell response. The mutual orientation between the respective tandem peptides (45-115 and 115-45) is critical for the T-cell response. These peptidic constructs possess distinct properties of antigenicity and immunogenicity but both allowed to reveal the existence of a specific T-cell response normally undetectable using 115-131 peptide alone. This immunopharmacological approach should be useful in the rational design and construction of vaccines.

摘要

45 - 69肽是一种源自HIV nef蛋白的辅助性T细胞表位,具有很强的免疫原性。在用低剂量且无任何佐剂的45 - 69肽免疫Lou/M大鼠后,观察到了T细胞增殖反应。已知对曼氏血吸虫蛋白Sm28GST抗原的115 - 131肽的T细胞反应需要肽构建体载体的存在。我们在此证明,使用由115 - 131肽和45 - 69肽串联合成产生的肽构建体(115 - 45和45 - 115肽),在无佐剂的情况下可获得针对115 - 131肽的T细胞反应。两种肽的共价结合是必要的,因为共同注射45 - 69和115 - 131肽不足以诱导可检测到的抗115 - 131 T细胞反应。各个串联肽(45 - 115和115 - 45)之间的相互取向对T细胞反应至关重要。这些肽构建体具有不同的抗原性和免疫原性特性,但两者都能揭示通常单独使用115 - 131肽无法检测到的特异性T细胞反应的存在。这种免疫药理学方法应有助于疫苗的合理设计和构建。

相似文献

1
Improvement of the T-cell response to a non immunogenic peptide by its tandem association with a highly efficient T-helper peptide.通过与高效辅助性T细胞肽串联结合来改善T细胞对非免疫原性肽的反应。
Immunopharmacology. 1994 Nov-Dec;28(3):215-22. doi: 10.1016/0162-3109(94)90057-4.
2
Improvement of the T-cell response to a non-immunogenic peptide by its tandem association with a highly efficient T-helper peptide.通过与高效T辅助肽串联结合来改善T细胞对非免疫原性肽的反应。
Immunopharmacology. 1994 Sep-Oct;28(2):137-43. doi: 10.1016/0162-3109(94)90029-9.
3
T helper cell epitopes of the human immunodeficiency virus (HIV-1) nef protein in rats and chimpanzees.
Mol Immunol. 1992 Apr;29(4):489-99. doi: 10.1016/0161-5890(92)90006-j.
4
Analysis of antigenicity and immunogenicity of five different chemically defined constructs of a peptide.
Mol Immunol. 1992 Jun;29(6):793-800. doi: 10.1016/0161-5890(92)90189-5.
5
Antigenicity and immunogenicity of a multiple peptidic construction of the Schistosoma mansoni Sm-28 GST antigen in rat, mouse, and monkey. 1. Partial protection of Fischer rat after active immunization.曼氏血吸虫Sm-28 GST抗原的多重肽构建体在大鼠、小鼠和猴体内的抗原性和免疫原性。1. 主动免疫后对Fischer大鼠的部分保护作用。
J Immunol. 1991 Mar 15;146(6):1987-95.
6
Human immunodeficiency virus type 1 Nef epitopes recognized in HLA-A2 transgenic mice in response to DNA and peptide immunization.1型人类免疫缺陷病毒Nef表位在HLA - A2转基因小鼠中对DNA和肽免疫的应答中被识别。
Virology. 2000 Jul 20;273(1):112-9. doi: 10.1006/viro.2000.0360.
7
Analysis of the immune response elicited by a multiple antigen peptide (MAP) composed of two distinct protective antigens derived from the parasite Schistosoma mansoni.对由源自曼氏血吸虫寄生虫的两种不同保护性抗原组成的多抗原肽(MAP)引发的免疫反应的分析。
Parasite Immunol. 1997 Jan;19(1):1-11. doi: 10.1046/j.1365-3024.1997.d01-138.x.
8
Induction of cytotoxic T-cell activity by the protective antigen of Schistosoma mansoni Sm28GST or its derived C-terminal lipopeptide.曼氏血吸虫Sm28GST的保护性抗原或其衍生的C末端脂肽诱导细胞毒性T细胞活性。
Scand J Immunol. 1996 Nov;44(5):485-92. doi: 10.1046/j.1365-3083.1996.d01-340.x.
9
Schistosoma mansoni gene GP22 encodes the tegumental antigen sm25: (1) antibodies to a predicted B-cell epitope of Sm25 cross-react with other candidate vaccine worm antigens; (2) characterization of a recombinant product containing tandem-repeats of this peptide as a vaccine.曼氏血吸虫基因GP22编码体表抗原sm25:(1) 针对Sm25预测B细胞表位的抗体与其他候选疫苗蠕虫抗原发生交叉反应;(2) 对含有该肽串联重复序列的重组产物作为疫苗进行特性分析。
Parasite Immunol. 2000 Aug;22(8):381-95. doi: 10.1046/j.1365-3024.2000.00316.x.
10
Identification of a candidate vaccine peptide on the 37 kDa Schistosoma mansoni GAPDH.曼氏血吸虫37 kDa甘油醛-3-磷酸脱氢酶上一种候选疫苗肽的鉴定
Vaccine. 2000 Apr 3;18(19):2039-48. doi: 10.1016/s0264-410x(99)00521-6.